# NAPROXEN SODIUM

NDC: 68210-4096
Generic name: NAPROXEN SODIUM
Labeler / Manufacturer: SPIRIT PHARMACEUTICALS,LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200702

FDA application: ANDA091353

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68210-4096"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68210-4096
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a690dc39-95f2-4853-a291-05d7dc9a1551